Literature DB >> 21344388

HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.

Hong-Sheng Zhang1, Zheng Ruan, Wei-Wei Sang.   

Abstract

Chromatin remodeling, especially in relation to the transactivator Tat, is an essential event for human immunodeficiency virus-1 (HIV-1) transcription. Curcumin has been shown to suppress pathways linked to HIV-1 replication. We investigated whether curcumin had the potential to inhibit Tat-induced long terminal repeat region (LTR) transactivation. As we shown, curcumin inhibited Tat-induced LTR transcativation, while knockdown of histone deacetylase 1 (HDAC1) by siRNA potentiated Tat-induced HIV-1 transcativation. Curcumin reversed Tat-induced down-regulation of HDAC1 expression in multinuclear activation of galactosidase indicator (MAGI) cells. Treatment with curcumin reversed Tat-induced dissociation of HDAC1 from LTR; and curcumin caused a decline in the binding of p65/NFκB to LTR promoters stimulated by Tat. Curcumin attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Curcumin reversed Tat-mediated reduction in AMPK activation and downstream acetyl-CoA carboxylase (ACC) activation. Collectively, our data provide new insights into understanding of the molecular mechanisms of curcumin inhibited Tat-regulated transcription, suggesting that targeting AMPK/HDAC1/NFκB pathway could serve as new anti-HIV-1 agents.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21344388     DOI: 10.1002/jcp.22691

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.

Authors:  Wen Xie; Denis Agniel; Andrey Shevchenko; Sergey V Malov; Anton Svitin; Nikolay Cherkasov; Marianna K Baum; Adriana Campa; Simani Gaseitsiwe; Hermann Bussmann; Joseph Makhema; Richard Marlink; Vladimir Novitsky; Tun-Hou Lee; Tianxi Cai; Stephen J O'Brien; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-06       Impact factor: 2.205

Review 2.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

3.  Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets.

Authors:  Dhivya Shanmugarajan; Prabitha P; B R Prashantha Kumar; B Suresh
Journal:  RSC Adv       Date:  2020-08-25       Impact factor: 4.036

4.  The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2.

Authors:  Victor H Ferreira; Aisha Nazli; Sara E Dizzell; Kristen Mueller; Charu Kaushic
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

5.  BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection.

Authors:  Irene Guendel; Beatrix W Meltzer; Alan Baer; Seth M Dever; Kristoffer Valerie; Jia Guo; Yuntao Wu; Kylene Kehn-Hall
Journal:  Virol J       Date:  2015-03-06       Impact factor: 4.099

6.  Effects of Ghrelin on Triglyceride Accumulation and Glucose Uptake in Primary Cultured Rat Myoblasts under Palmitic Acid-Induced High Fat Conditions.

Authors:  Lingling Han; Jia Li; Ying Chen; Wei Wang; Dan Zhang; Guoliang Liu
Journal:  Int J Endocrinol       Date:  2015-12-02       Impact factor: 3.257

7.  Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model.

Authors:  Piyawadee Wicha; Jiraporn Tocharus; Adchara Janyou; Jinatta Jittiwat; Chatchawan Changtam; Apichart Suksamrarn; Chainarong Tocharus
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

8.  Inhibition of HIV-1 by curcumin A, a novel curcumin analog.

Authors:  Namita Kumari; Amol A Kulkarni; Xionghao Lin; Charlee McLean; Tatiana Ammosova; Andrey Ivanov; Maria Hipolito; Sergei Nekhai; Evaristus Nwulia
Journal:  Drug Des Devel Ther       Date:  2015-09-03       Impact factor: 4.162

9.  Curcumin inhibits the replication of enterovirus 71 in vitro.

Authors:  Ying Qin; Lexun Lin; Yang Chen; Shuo Wu; Xiaoning Si; Heng Wu; Xia Zhai; Yan Wang; Lei Tong; Bo Pan; Xiaoyan Zhong; Tianying Wang; Wenran Zhao; Zhaohua Zhong
Journal:  Acta Pharm Sin B       Date:  2014-07-24       Impact factor: 11.413

10.  Curcumin inhibits HIV-1 by promoting Tat protein degradation.

Authors:  Amjad Ali; Akhil C Banerjea
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.